Fundraising Fox

Elia Stupka

Investor

Managing Director at Angelini Ventures · Venture Partner at First Star Ventures

Rome | Singapore

FoundedGenialis

About

Elia Stupka is a founding Managing Director at Angelini Ventures with over 20 years of executive experience in healthcare and life sciences. He was previously on the leadership team of Health Catalyst through its 2019 NASDAQ IPO, and earlier held roles as Senior Director of Data Science at Dana-Farber Cancer Institute, Venture Partner at First Star Ventures, and Director at Boehringer Ingelheim Pharma. Earlier in his career he was a genomics scientist, including work on the first human genome annotation team in Cambridge and co-directing the genomics research center at San Raffaele Hospital in Milan; he holds a PhD in Computer Science from Leiden University and degrees in Biology from the University of York.

LinkedIn ↗X / Twitter ↗

Invests in

AI & Machine LearningBiotechDeep TechDigital HealthHealthtech

Experience

  1. Angelini VenturesManaging Directorcurrent2021 — presentGlobal
  2. leapcureStrategic Advisorcurrent2020 — present
  3. First Star VenturesVenture Partnercurrent2019 — presentBoston, Massachusetts, United States
  4. Duality TechnologiesStrategic Advisorcurrent2019 — presentTel Aviv, Israel
  5. Entropica LabsStrategic Advisorcurrent2018 — presentSingapore
  6. Pulse Infoframe Inc.Strategic Advisorcurrent2018 — present
  7. Reboot RxStrategic Advisorcurrent2018 — presentBoston, Massachusetts, United States
  8. Alkahest, Inc.Scientific Advisory Board Membercurrent2016 — present
  9. GenialisMember Board Of Directorscurrent2017 — presentGreater Boston Area
  10. GenialisStrategic Advisorcurrent2015 — presentSlovenia
  11. Healx LtdAdvisorcurrent2016 — presentCambridge, United Kingdom
  12. EspeRare foundationScientific Advisorcurrent2015 — presentGeneva Area, Switzerland
  13. Health CatalystStrategic Advisor2020 — 2024
  14. Health CatalystSVP and General Manager - Life Sciences Business2019 — 2020Cambridge, MA
  15. Health CatalystChief Analytics Officer, SVP - Life Sciences Business2018 — 2019Cambridge, MA
  16. Cardea Bio Inc.Innovation Councilor2020 — 2023San Diego, California, United States
  17. WSAFE IMPACT VENTURE BUILDERStrategic Advisor2020 — 2022Ho Chi Minh City, Vietnam
  18. reach52Advisor2020 — 2022Singapore
  19. RaremarkAdvisor2018 — 2022London, UK
  20. United World College of the Adriatic - Collegio del Mondo Unito dell'Adriatico ONLUSBoard Member2016 — 2018

Education

  1. MIT Sloan School of ManagementLeading Innovative Enterprises Program, Innovation2008
  2. Leiden UniversityDoctor of Philosophy (PhD), Computer Science
  3. University of YorkM.Res., Biomolecular Science1998 — 1999
  4. University of YorkBachelor of Science (B.Sc.), Biology1995 — 1998
  5. United World CollegeInternational Baccalaureate, Biology1993 — 1995
  6. Liceo Scientifico "Galileo Galilei"Maturita1990 — 1993

Skills & more

Leadership22Strategy23Analysis17Perl38R23Science99Life Sciences99Computational Biology99Bioinformatics99Genomics99Biotechnology76Data Mining67
+12 moreResearchBusiness DevelopmentData AnalysisGeneticsStart-upsR&DSequence AnalysisTranscriptomicsSystems BiologySequencingRNAseqBiology

Languages Czech · English · French · Georgian · Italian · Spanish

From Elia's professional profile.

Same school

Also attended MIT Sloan School of Management427

Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor

+ 421 more

Also attended Leiden University72

Andrea van ElsasInvestor at Third Rock VenturesFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgJeroen PlinkVenture Partner at LegalTechThijs SchaapInvestment manager at NoaberRoel BulthuisInvestor at SynconaLeonie MekelChief Financial Officer at SET Ventures

+ 66 more

Also attended University of York32

Bob ThomasPartner at OxxMarkInvestor at Boundary CapitalPhil VenablesVenture Partner at Ballistic VenturesAnthony AvedissianPartner at Canonical CryptoConor ScanlanAssociate Partner at Nauta CapitalRosanne WhalleyCEO at AHL Venture Partners

+ 26 more

Shared employers

Also worked at reach521

Gavin TeoGeneral Partner at Altara Ventures

Also worked at Dana-Farber Cancer Institute27

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Dave BarrettSenior Advisory Partner at Polaris PartnersMargaux FosterAnalyst at redalpineWeihan LiuAssociate at Cure VenturesRosie BellDirector of Marketing at LRVHealthTaruho KurodaImpact Partner at Fresco Capital

+ 21 more

Also worked at San Raffaele S.p.A.2

Roberto MolinaroSenior Analyst at XGEN VentureBianca BenattiJr. Analyst at XGEN Venture

Also worked at IBM547

Ken ChenaultInvestment Team at General CatalystRoger KrakoffGeneral Partner at Monta Vista CapitalAvi BharadwajInvestment Director at Intel CapitalTejAdvisor at Clear VenturesEricAdvisor at Clear VenturesKT MooreAdvisor at Clear Ventures

+ 541 more

Investments

Board seats

Comind TechnologiesGenialisSerenis

Per the firm's website.

Colleagues at Angelini Ventures

Paolo Di Giorgio
CEO and Managing Director at Angelini Ventures
Regina Hodits
Managing Director at Angelini Ventures
Tanja Dowe
Managing Director at Angelini Ventures

Network4

Drew Volpe
Founding Partner at First Star Ventures
Julia Svennerstål-Hawkins
General Partner at Phoenix Court
Millie Liu Liu
Founding Partner at First Star Ventures
Teddy Blank
Partner at First Star Ventures

Investors connected to Elia in public investor directories — a warm-intro map.